Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric moxidectin dose-finding study for onchocerciasis
PACTR201907565746388Phase 1Completed
- Sponsor
- Medicines Development for Global Health
- Start
- Jan 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of moxidectin in onchocerciasis (3 cohorts), sponsored by Medicines Development for Global Health. Primary endpoint: Area under the plasma concentration versus time curve of moxidectin. Started Jan 2020; status: completed.
02
Drugs
moxidectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on PACTR201907565746388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907565746388.